PEPTIDES (175 Offers)
Shipped International
Sun Pharmaceuticals Ind. Ltd.
For Subqutaneous Injection
Composition: Human Menopausal Gonadotropin
Dosage: 150 IU/vial
Unit: 10 mL Multidose Vial
Manufactured by Sun Pharmaceuticals
$75.00
Coming Soon!
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Somatropin (191aa) Lyophilized recombinant human growth hormone
10 IU per vial
Form Lyophilized Powder
Packaging 1 Kit (10 × 2 mL Vials)
Estimated Half-Life Approximately 2–3 Hours
Detection Up to 1–2 Days
Primary Mechanism GH Receptor Agonism / IGF-1 Induction
GH / IGF-1 Impact High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance BPC-157 Lyophilized synthetic pentadecapeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Angiogenesis / VEGF Pathway Upregulation
Tissue Repair / Healing High (preclinical)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance GHK-Cu (Copper Peptide) Lyophilized copper-binding tripeptide
50 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Copper-Dependent Collagen & Tissue Remodeling
Tissue Repair / Healing High (preclinical)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Thymosin Beta-4 Lyophilized synthetic peptide (full-length, 43 aa)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Actin Cytoskeleton Regulation / Cell Migration
Tissue Repair / Healing Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Product Information
Dragon PharmaCompound Details
Active Substance TB-500 (Thymosin Beta-4 Fragment) Lyophilized healing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Actin Cytoskeleton Regulation / Cell Migration
Tissue Repair / Healing High (preclinical)
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance GHK-Cu (Copper Peptide) Lyophilized copper-binding tripeptide
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Copper-Dependent Collagen & Tissue Remodeling
Tissue Repair / Healing High (preclinical)
$55.00
Coming Soon!
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Human Menopausal Gonadotropin (HMG) Lyophilized FSH & LH gonadotropin
150 IU per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 1–2 Days (FSH)
Detection Up to several weeks
Primary Mechanism FSH & LH Receptor Agonism
Fertility / Gonadal Support High
Coming Soon!
Product Information
Dragon PharmaCompound Details
Active Substance KPV (Ac-Lys-Pro-Val-NH₂) Lyophilized anti-inflammatory tripeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Sterile Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Melanocortin Pathway / NF-κB Modulation
Anti-Inflammatory Impact High
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Kisspeptin Lyophilized peptide hormone (KISS1 analogue)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism KISS1R Agonism / Upstream GnRH Stimulation
HPTA / Gonadotropin Support High
Product Information
Dragon PharmaCompound Details
Active Substance PE 22-28 Lyophilized PACAP-derived neuropeptide fragment
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Sterile Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism PACAP Receptor-Mediated Neuroprotection
Neuroprotective / Anti-Inflammatory Impact Moderate
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance SS-31 (Elamipretide) Lyophilized mitochondrial-targeted tetrapeptide
50 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2–4 Hours
Detection Up to several weeks
Primary Mechanism Cardiolipin Binding / Mitochondrial Membrane Stabilisation
Mitochondrial / Cellular Energy Impact Moderate
